Conclusions: Compared with patients with no hypoglycemia-related claims in year 1 after basal insulin initiation, patients with a hypoglycemia-related claim had a greater burden of complications and ...

Please provide your email address to receive an email when new articles are posted on . Insulin efsitora alfa conferred noninferior HbA1c reductions vs. insulin degludec in two phase 3 trials. Level ...

Please provide your email address to receive an email when new articles are posted on . Adults with diabetes receiving both basal and bolus insulin through a smart pen miss about six doses every 14 ...

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the ...